ArticlePloS one2026
Uptake of measles second dose vaccine among children aged 15-35 months at Mettu Woreda, Illu Aba Bor Zone, Ethiopia: A community-based cross-sectional study.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMeasles remains a significant global health threat, especially for Children. Its prevention can be achieved through a safe and affordable vaccine. However, there is a paucity of information about the uptake of the measles second-dose vaccine and associated factors in Ethiopia, particularly in Mettu Woreda. Furthermore, this study examined understudied variable maternal trust in healthcare workers.
objectivesTo assess uptake of measles second dose vaccine and associated factors among children aged 15-35 months at Mettu woreda, Illu Aba bor zone, 2024.
methodsA community-based cross-sectional study was conducted from May to June of 2024 among 458 mothers/caregivers with Children aged 15-35 months using a systematic sampling technique. Data was collected using interviews, administered questionnaires. The Statistical Package for the Social Sciences software version 27 was used to analyze the data. Binary logistic regression was used to identify factors associated with the uptake of measles second dose vaccine at P-value < 0.05.
resultsCoverage of the measles second dose vaccine was 58.5% (95% CI: 53.8-63.1). Factors positively associated with the uptake include maternal age (26-30 [AOR: 2.7, 95% CI (1.46-5.05)], 31-35 [AOR: 3.3, 95% CI (1.52-7.13)]), education; primary([AOR: 3.1, 95% CI (1.35-7.26)], secondary[AOR: 4.3, 95% CI (2.03-9.30)]), knowledge[AOR: 2, 95% CI (1.11-3.64)], information about MCV2[AOR: 3.7, 95% CI (2.10-6.56)], waiting time[AOR: 3, 95% CI (1.45-6.17)], while availability of vaccination service[AOR: 0.4, 95% CI (0.24-0.78)], and lack of trust in health workers[AOR: 0.3, 95% CI (0.18-0.55)] negatively affected vaccine uptake.
conclusionThe uptake of the measles second-dose vaccine among children aged 15-35 months is below district and national targets. Maternal age, education, knowledge, information access, trust in healthcare workers, antenatal care, waiting times, and service availability were all associated. Improved community awareness and addressing healthcare facility closures are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.